Literature DB >> 11212325

Proteasomes in apoptosis: villains or guardians?

C Wójcik1.   

Abstract

The proteasome (multicatalytic proteinase complex, prosome) is a major cytoplasmic proteolytic enzyme, responsible for degradation of the vast majority of intracellular proteins. Proteins degraded by the proteasome are usually tagged with multiple ubiquitin moieties, conjugated to the substrates by a complicated cascade of enzymes. Over the last years, evidence has accumulated that changes in the expression and activity of the different components of the ubiquitin-proteasome system occur during apoptosis. Proteasome inhibitors have been used to induce apoptosis in various cell types, whereas in others, these compounds were able to prevent apoptosis induced by different stimuli. The proteasome mediated step(s) in apoptosis is located upstream of mitochondrial changes and caspase activation, and can involve in different systems Bcl-2, Jun N-terminal kinase, heat shock proteins, Myc, p53, polyamines and other factors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 11212325     DOI: 10.1007/s000180050483

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  14 in total

1.  Nocardia asteroides strain GUH-2 induces proteasome inhibition and apoptotic death of cultured cells.

Authors:  Daniel P Barry; Blaine L Beaman
Journal:  Res Microbiol       Date:  2006-12-15       Impact factor: 3.992

2.  Inhibition of Proteasome Activity Induces Formation of Alternative Proteasome Complexes.

Authors:  Vanessa Welk; Olivier Coux; Vera Kleene; Claire Abeza; Dietrich Trümbach; Oliver Eickelberg; Silke Meiners
Journal:  J Biol Chem       Date:  2016-04-18       Impact factor: 5.157

Review 3.  Bortezomib as the first proteasome inhibitor anticancer drug: current status and future perspectives.

Authors:  D Chen; M Frezza; S Schmitt; J Kanwar; Q P Dou
Journal:  Curr Cancer Drug Targets       Date:  2011-03       Impact factor: 3.428

Review 4.  Overview of proteasome inhibitor-based anti-cancer therapies: perspective on bortezomib and second generation proteasome inhibitors versus future generation inhibitors of ubiquitin-proteasome system.

Authors:  Q Ping Dou; Jeffrey A Zonder
Journal:  Curr Cancer Drug Targets       Date:  2014       Impact factor: 3.428

Review 5.  The role of the ubiquitin proteasome system in ischemia and ischemic tolerance.

Authors:  Robert Meller
Journal:  Neuroscientist       Date:  2009-01-30       Impact factor: 7.519

6.  Degradation and dephosphorylation of focal adhesion kinase during okadaic acid-induced apoptosis in human neuroblastoma cells.

Authors:  Bhumsoo Kim; Cynthia M van Golen; Eva L Feldman
Journal:  Neoplasia       Date:  2003 Sep-Oct       Impact factor: 5.715

7.  Expression of a K48R mutant ubiquitin protects mouse testis from cryptorchid injury and aging.

Authors:  Reza J Rasoulpour; Heidi A Schoenfeld; Douglas A Gray; Kim Boekelheide
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

8.  Two closely related ubiquitin C-terminal hydrolase isozymes function as reciprocal modulators of germ cell apoptosis in cryptorchid testis.

Authors:  Jungkee Kwon; Yu-Lai Wang; Rieko Setsuie; Satoshi Sekiguchi; Yae Sato; Mikako Sakurai; Mami Noda; Shunsuke Aoki; Yasuhiro Yoshikawa; Keiji Wada
Journal:  Am J Pathol       Date:  2004-10       Impact factor: 4.307

9.  The tumor proteasome as a novel target for gold(III) complexes: implications for breast cancer therapy.

Authors:  Vesna Milacic; Q Ping Dou
Journal:  Coord Chem Rev       Date:  2009       Impact factor: 22.315

10.  Degradation of cAMP-responsive element-binding protein by the ubiquitin-proteasome pathway contributes to glucotoxicity in beta-cells and human pancreatic islets.

Authors:  Safia Costes; Brigitte Vandewalle; Cécile Tourrel-Cuzin; Christophe Broca; Nathalie Linck; Gyslaine Bertrand; Julie Kerr-Conte; Bernard Portha; François Pattou; Joel Bockaert; Stéphane Dalle
Journal:  Diabetes       Date:  2009-02-17       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.